Form 4: NeuroPace Director Uri Geiger Acquires Shares

NeuroPace Inc. Director Uri Geiger acquired 715 shares of common stock at $16.59 per share as part of his compensation.

Summary

• Uri Geiger, a Director of NeuroPace Inc. (NPCE), acquired 715 shares of common stock.
• The transaction occurred on December 19, 2025, at a price of $16.59 per share.
• These shares were issued to Mr. Geiger pursuant to the Issuer's non-employee director compensation policy, in lieu of quarterly retainer fees.
• Following this transaction, Mr. Geiger directly beneficially owns 13,945 shares of common stock.
• Additionally, Mr. Geiger indirectly beneficially owns 4,432,948 shares through Accelmed Partners II LP, where he has sole voting and dispositive power as the managing partner of Accelmed LLC, the general partner.

Sentiment

Score: 6

Explanation: The sentiment is mildly positive as it reflects a director increasing their ownership, even if for compensation. It's a routine, pre-planned event, so it doesn't indicate significant new positive or negative developments for the company.

Positives

• Director Uri Geiger's acquisition of shares, even as compensation, increases insider ownership, which can be viewed as a minor positive signal of alignment with shareholder interests.

Future Outlook

This filing reports a specific, pre-scheduled transaction and does not contain broader forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This is a routine insider transaction related to director compensation, which is a common practice across publicly traded companies. It does not provide specific insights into broader industry trends or competitive landscape beyond the company's standard governance practices.

Comparison to Industry Standards

• The practice of compensating non-employee directors with equity in lieu of cash retainer fees is a common corporate governance standard across various industries, aligning director interests with those of shareholders.

Corporate Governance

Related Party Transactions

• Uri Geiger's indirect beneficial ownership of 4,432,948 shares is through Accelmed Partners II LP. Mr. Geiger is the managing partner of Accelmed LLC, which is the general partner of Accelmed Partners II GP, L.P., which in turn is the general partner of Accelmed Partners II LP. This structure indicates a related party relationship for the indirect holdings.

Stakeholder Impact

• Shareholders: The increase in director ownership, even through compensation, can be viewed as a minor positive, signaling continued alignment of management interests with shareholder value.
• Employees: No direct impact on employees is indicated by this filing.

Key Dates

Recommendation

This Form 4 details a routine, pre-scheduled acquisition of shares by a director as part of their compensation package. While an increase in insider ownership can be a minor positive signal, this specific transaction does not provide new material information that would fundamentally alter the investment thesis for NeuroPace Inc. It is a standard compensation event and does not warrant a strong buy or sell recommendation based solely on this filing.

Keywords

NeuroPace, NPCE, Form 4, Insider Transaction, Director Compensation, Stock Acquisition, Uri Geiger, Beneficial Ownership